Prosecution Insights
Last updated: August 30, 2026
Application No. 18/719,711

DRUG DELIVERY ARRANGEMENT COMPRISING A TISSUE RECEIVING ELEMENT

Non-Final OA
Filed
Jun 13, 2024
Priority
Dec 15, 2021 — EU 21315276.2 +1 more
Examiner
GHANNOUM, ISSA JAMIL
Art Unit
Tech Center
Assignee
Sanofi S.A.
OA Round
1 (Non-Final)
Grant Probability
Favorable
1-2
OA Rounds

Examiner Intelligence

Grants only 0% of cases
0%
Career Allowance Rate
0 granted / 0 resolved
-60.0% vs TC avg
Minimal +0% lift
Without
With
+0.0%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
13 currently pending
Career history
4
Total Applications
across all art units

Statute-Specific Performance

§103
79.3%
+39.3% vs TC avg
§102
17.2%
-22.8% vs TC avg
§112
3.5%
-36.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 0 resolved cases

Prosecution Timeline

Jun 13, 2024
Application Filed
Aug 17, 2026
Non-Final Rejection mailed (current)

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
Grant Probability
Low
PTA Risk
Based on 0 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month